Septerna, Inc. (SEPN)

↓ Download CSV

CIK 0001984086 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Septerna, Inc. reported revenue of $45.95M, up 4174.5% from the prior year. The company ran a net loss, with a net margin of -106.4%. It held $596.19M in total assets against $214.26M in total liabilities.

Key ratios (FY2025)

-148.6%
Operating margin
-106.4%
Net margin
-12.8%
Return on equity
+4174.5%
Revenue growth (YoY)
Metric (FY)2025202420232022
Revenue$45.95M$1.07M$151.0K
Operating Income-$68.30M-$80.82M$2.08M
Net Income-$48.88M-$71.80M$4.18M
EPS (Diluted)$-1.10$-7.26$0.29
Total Assets$596.19M$456.55M$130.87M
Total Liabilities$214.26M$36.51M$20.03M
Shareholders' Equity$381.93M$420.05M-$38.37M-$44.20M
Cash & Equivalents$120.72M$238.20M$88.48M
Operating Cash Flow$110.19M-$67.47M-$38.72M
Capital Expenditures$518.0K$2.10M$2.88M
Shares Outstanding44.81M44.42M3.17M